Skip to content
Review Open access

Medicinal Plants and Natural Bioactives in Geroprotection: Integrating Neuroprotective, Metabolic, and Immuno-Modulatory Mechanisms with AI-Driven Nutriphenomics

Oct 2026 · Pharmaceuticals · 0 citations

TL;DR

Current evidence supports further investigation of medicinal plants as candidate modulators of biological aging and healthspan-related processes, while emphasizing the need for standardized preparations, robust clinical studies, and mechanistically informed translational research.

Abstract

Aging is a multifactorial biological process characterized by progressive alterations in cellular homeostasis, metabolic regulation, immune function, and neurological integrity, contributing to chronic disease, functional decline, and reduced healthspan. Natural bioactive compounds are increasingly investigated as potential geroprotective agents because of their ability to modulate multiple pathways associated with biological aging. Polyphenols, alkaloids, terpenoids, peptides, and related phytochemicals have demonstrated antioxidant, anti-inflammatory, neuroprotective, metabolic, and immunomodulatory effects. However, modulation of aging-related pathways should be distinguished from direct evidence of lifespan extension. Medicinal plants, traditional medicine, and locally consumed functional foods represent important yet comparatively underexplored sources of bioactive compounds with potential relevance to healthy aging. This review synthesizes molecular, cellular, preclinical, and clinical evidence on medicinal plants and their bioactive constituents, with emphasis on neuroprotection, metabolic homeostasis, and immune regulation. Key mechanisms include modulation of oxidative stress, mitochondrial function, nutrient-sensing pathways, autophagy, cellular senescence, neuroinflammation, and chronic low-grade inflammation. Advances in analytical chemistry, molecular docking, network pharmacology, and multi-omics approaches are also considered for their role in strengthening mechanistic characterization and identifying potential responder profiles. Overall, current evidence supports further investigation of medicinal plants as candidate modulators of biological aging and healthspan-related processes, while emphasizing the need for standardized preparations, robust clinical studies, and mechanistically informed translational research.

Read PDF

Similar papers

Review Open access Oct 2026

Molecular mechanisms and translational therapeutic potential of plant-derived bioactives in metabolic and neurodegenerative disorders

Metabolic disorders and neurodegenerative diseases have emerged as a set of interrelated disorders caused by inflammatory processes, oxidative stress, mitochondrial impairment and disruption of cellular signalling mechanisms. Metabolic disorders like obesity and type 2 diabetes, along with neurodegenerative diseases su...

R. Keerthivasan, R. Sudarshan · 0 citations
Review Open access Oct 2026

Bee-Derived Products in Neurodegenerative Diseases: Bioactive Constituents, Redox-Modulating Mechanisms, Evidence, and Translational Perspectives

Oxidative stress, mitochondrial dysfunction, and chronic neuroinflammation are closely interconnected processes involved in the pathogenesis and progression of neurodegenerative diseases. Bee-derived products, including honey, propolis, royal jelly, bee pollen, bee bread, and bee venom, contain diverse bioactive consti...

Jakub Garbarek, Oskar Hys, Alina Woźniak et al. · 0 citations
Open access Sep 2026

Medicinal plants and their bioactive phytochemicals in neuroprotection: modulating oxidative stress and regulated cell death

This editorial argues that the field should move beyond “antioxidant activity” towards a framework in which plant-derived compounds are evaluated for their ability to modulate redox-sensitive signalling, mitochondrial function, neuroinflammation, and regulated cell-death processes such as apoptosis and ferroptosis.

I. J. Sagbo, P. Ndhlovu, Masixole Makhaba et al. · 0 citations
Review Open access Oct 2026

Bioactive metabolites and botanical preparations from plants used as medicines and foods in ulcerative colitis: a mechanism-oriented narrative review of multi-target regulation

Ulcerative colitis (UC) is a chronic relapsing inflammatory bowel disease with a complex pathophysiology involving immune dysregulation, gut microbiota dysbiosis, intestinal barrier impairment, oxidative stress, and regulated cell death. Current therapeutic strategies, including 5-aminosalicylic acid, corticosteroids,...

Jia-Xue Chen, Ji-Hong He, Zi-Wen Xu et al. · 0 citations
Review Oct 2026

Exploring the medicine-food potential of cucurbitacins: From phytochemistry, biosynthesis and structure-activity relationships to translational perspectives.

Future multidisciplinary efforts integrating structural optimization, biosynthetic engineering, delivery technologies, and regulatory considerations will be essential for balancing efficacy, safety, and sensory quality in cucurbitacins, thereby supporting their rational development and further evaluation of their broad...

Chao Fang, Yan-Li Zhang, Hai-Xia Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.